// App-Quantinova.ai

279 : Phase I study of the nivolumab combined with IFN-B in patients with advanced melanoma

Researchers

Presenter

  • T. Fujimura

Principal Investigators

  • Y. Kambayashi

  • S. Furudate

  • T. Hidaka

  • S. Aiba

Medical Centers

  • Department of Dermatology Tohoku University Graduate School of Medicine, Sendai, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

  • IFN-lambda

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved